UNSPSC 51282803: Ornidazole

This classification denotes an amebicide, antitrichomonal agent, and radiation-sensitizing agent with the molecular formula C7H10ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62XCK0G93T, chemically known as 1h-imidazole-1-ethanol, alpha-(chloromethyl)-2-methyl-5-nitro- but generally known as ornidazole, which bears US NIH Compound Identifier 28061. European Medicines Agency schedules Ornidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09464MIG.

UNSPSC 51282803 Ornidazole is a Commodity-tier code tracking pharmaceutical products used in state and local health and safety operations. Recent state and local solicitations under this code show procurement of specific pharmaceutical agents — antibiotic and anti-parasitic drugs, naloxone, and related medical supplies — sourced through both direct purchase and cooperative purchasing vehicles. State and local health departments, counties, and community health authorities issue these contracts to maintain inventory for emergency response, disease treatment, and harm-reduction programs. Issuing bodies span state health departments and county-level public health and community services agencies, with purchases typically structured as annual or multi-year supply agreements with quarterly or on-demand delivery.

Activity appears geographically dispersed across multiple states, with recent opportunities posted from Illinois and Florida. The Illinois Department of Public Health awarded a $2.999 million piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an IFB process, with a 12-month initial term and two one-year renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2026. Both procurements required vendors to meet federal compliance standards and included multi-year terms; cooperative purchasing vehicles and state piggyback programs appear to structure larger pharmaceutical supply contracts alongside direct county competitive bidding.